Rheumatology

“Considering medical appointments, laboratory tests, medications, and indirect costs, juvenile idiopathic arthritis generates elevated costs, which results in a high economic impact for the family,” investigators stated.

The post hoc analyses evaluated health-related quality of life and efficacy across 4 subgroups treated with either ixekizumab or adalimumab.

Dr. Mehta talks about rheumatologic testing, joint examinations, and the great relationships he gets to develop with his patients.

The Fast-Track Clinic reduced hospitalization rates for patients with polymyalgia rheumatica, which is helpful as symptoms of PMR can mimic other diseases, leading to hospitalization to rule out other conditions.

E Michael Lewiecki, MD, discusses his CCR West presentations entitled, “Controversies in Osteoporosis” and “What's New in Osteoporosis for 2021?”

Dr. Mehta highlights some of the challenges that come with treating pediatric rheumatology patients and how he handles them.

In this video interview, Dr. Jay Mehta discusses his presentation on pediatric rheumatology for the American Association of Pediatrics Conference.

Upadacitinib achieved positive results from both Phase 3 SELECT-AXIS clinical trials, which focused on patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 8, 2021.

The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.

Limited information is available on the overall disease burden of axial spondyloarthritis (axSpA) in women, as they are generally underrepresented in clinical studies.

Veena Joy, MS, discusses Thermo Scientific’s recent FDA approval of their EliA SmDP-S test, which aides in the diagnosis of Systemic Lupus Erythematosus (SLE).

Test-retest reliability for Health Assessment Questionnaire–Disability Index and 36-item Short Form Health Survey physical functioning domain in patients with psoriatic arthritis was judged to be good and reasonable, respectively.

“Many patients with axial spondyloarthritis who receive treatment still experience disease-related burdens in different aspects of health-related quality of life,” investigators stated.

Few data exist for the use of golimumab in patients whose uveitis does not respond to adalimumab, a first-line biologic choice in refractory juvenile idiopathic arthritis-associated uveitis.

Patients with rheumatoid arthritis have a higher risk of depression, but how much greater? Take this quiz to test your knowledge of the prevalence of depression.

Sarah Stewart, PhD, discusses her study entitled "What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout."

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 1, 2021.

While telemedicine is a valuable tool to provide access to care for families seeking care within a small subspecialty with a limited supply of providers, there was a significantly lower amount of new pediatric patient visits in the beginning of the COVID-19 pandemic.

More patients with methotrexate intolerance receiving baricitinib 4 mg and adalimumab had no progression in radiographic progression at year 5 when compared with placebo.

Test your knowledge of the treatment and management of rheumatoid arthritis (RA) with our RA quizzes.

Looking specifically at patients who have been treated with biologic disease-modifying anti-rheumatic drugs, this study examines the risk of new or recurrent cancer.

“Considering the fact that people with one and the same clinical condition can vary substantially in terms of disability, there is a need to expand the assessment tools,” investigators stated.

“Understanding the role of ixekizumab will allow physicians to translate a higher Assessment of Spondyloarthritis International Society (ASAS) achievement to the improvements in the signs and symptoms reported by their patients,” investigators stated.

Catch up on Rheumatology Network's most recent highlights in rheumatoid arthritis news.

As genetics only play a small role in the risk of developing juvenile idiopathic arthritis, environmental factors, such as infections and antibiotic usage, are believed to be the main cause of the disease.

“In patients with rheumatoid arthritis, the prevalence of depression ranges between 14.8 and 22.5%, which is 2 to 3 times higher than in the general population,” investigators stated.

Results show how patients with psoriatic arthritis prioritize their decisions when choosing medication.

Jason Kolfenbach, MD, discusses his CCR West presentations entitled “Common Eye Disorders in Rheumatology Clinic” and “Top Secrets in Rheumatology.”

While the antioxidants in tea may reduce the risk of developing inflammatory diseases, such as rheumatoid arthritis, previous studies have shown inconclusive results.